Göğşen Önalan

ORCID: 0000-0003-3446-3751 · 13 papers in corpus · active 2004-2026

Study types

  • article 12
  • other 1

Condition tags

  • endometriosis 12
  • endometrioma 3
  • dysmenorrhea 1
  • infertility 1
other 2026
Accessory cavitated uterine mass: A rare cause of severe dysmenorrhea
Journal of the Turkish German Gynecological Association ·doi:10.4274/jtgga.galenos.2025.2025-10-5

We present a rare Müllerian anomaly known as "accessory cavitated uterine mass (ACUM)," which causes severe, refractory dysmenorrhea, and review the literature. A 17-year-old patient experienced severe, cyclic left-sided pelvic pain, correl…

article 2017
Effect of Etanercept on the Success of Assisted Reproductive Technology in Patients with Endometrioma
Gynecologic and obstetric investigation ·doi:10.1159/000484895

Aims: To determine the effects of a tumor necrosis factor inhibitor (etanercept) on pregnancy outcomes in patients with endometrioma who were treated with assisted reproductive technology. Methods: Sixty-eight infertile patients who had end…

article 2015
Etanercept, a TNF-alpha blocker, may improve pregnancy rates after IVF in patients with advanced endometriosis: a pilot study
·doi:10.1016/j.fertnstert.2015.07.650
article 2013
Effects of amifostine on endometriosis, comparison with N-acetyl cysteine, and leuprolide as a new treatment alternative: a randomized controlled trial
Archives of gynecology and obstetrics ·doi:10.1007/s00404-013-2963-0
article 2009
Doxycycline causes regression of endometriotic implants: a rat model
Human Reproduction ·doi:10.1093/humrep/dep106

BACKGROUND: Doxycycline (Dox) has a number of non-antibiotic properties. One of them is the inhibition of matrix metalloproteinase (MMP) activity. The aim of this study was to assess the effects of Dox in a rat endometriosis model. METHODS:…

article 2009
Fenofibrate causes regression of endometriotic implants: a rat model
Fertility and sterility ·doi:10.1016/j.fertnstert.2009.05.065
article 2008
Effect of amifostin-cytoprotective agent on the induction of endometriosis in an experimental rat model
·doi:10.1016/j.fertnstert.2008.07.1140
article 2007
Effect of matrix metalloproteinase (MMP) inhibitor – doxycycline on the induction of endometriosis in an experimental rat model
·doi:10.1016/j.fertnstert.2007.07.707
article 2007
Effect of peroxisome proliferator – activated receptor-α (PPAR-α) agonist-fenofibrate on the induction of endometriosis in an experimental rat model
·doi:10.1016/j.fertnstert.2007.07.708
article 2007
GnRH agonist and antagonist protocols for stage I–II endometriosis and endometrioma in in vitro fertilization/intracytoplasmic sperm injection cycles
Fertility and sterility ·doi:10.1016/j.fertnstert.2006.12.046
article 2005
Comparison of GnRH Agonist and Antagonist Protocols Among Patients with Mild-Moderate Endometriosis and Endometrioma: A Novel Clinical Approach
·doi:10.1016/j.fertnstert.2005.07.496
article 2005
Serum and follicular fluid levels of soluble Fas and soluble Fas ligand in IVF cycles
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2005.08.002
article 2004
Aspiration of ovarian endometriomas before intracytoplasmic sperm injection
Fertility and Sterility ·doi:10.1016/j.fertnstert.2004.02.117